Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Alexion Pharmaceuticals (NQ: ALXN )

161.75 USD +0.43 (+0.27%)
Official Closing Price Updated: 7:28 PM EST, Jan 26, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 2,360,600
Open 162.25
Bid (Size) 150.00 (1)
Ask (Size) 165.00 (5)
Prev. Close 161.32
Today's Range 161.69 - 162.60
52wk Range 72.67 - 162.60
Shares Outstanding 222,500,663
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
SHAREHOLDER ALERT: WeissLaw LLP Reminds NPA, THBR, GIX, and ALXN Shareholders About Its Ongoing Investigations
From PR Newswire
ALERT: Halper Sadeh LLP Investigates the Following Companies on Behalf of Shareholders - CHNG, OXFD, SMTX, OBLN, ALXN, BYFC, CIT
Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies: 
From PR Newswire

Performance

YTD
+3.15%
+3.15%
1 Month
+4.79%
+4.79%
3 Month
+34.79%
+34.79%
6 Month
+53.74%
+53.74%
1 Year
+53.61%
+53.61%

More News

Read More
INVESTIGATION ALERT: Halper Sadeh LLP Investigates ALXN, CHNG, RP, RNET, MDCA, NK; Shareholders Are Encouraged to Contact the Firm
From PR Newswire
Alexion to Report Fourth Quarter and Full Year 2020 Results on Thursday, February 4, 2021
From Business Wire News Releases
SHAREHOLDER ALERT: WeissLaw LLP Reminds MTSC, IPHI, ALXN and XLNX Shareholders About Its Ongoing Investigations
From PR Newswire
SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates ALXN, MGLN, FLIR, BEAT; Shareholders Are Encouraged to Contact the Firm
From GlobeNewswire News Releases
SHAREHOLDER ALERT: WeissLaw LLP Reminds EIDX, IPHI, ALXN, and XLNX Shareholders About Its Ongoing Investigations
From PR Newswire
Alexion Provides Update on Phase 3 Study of ULTOMIRIS® (ravulizumab-cwvz) in Hospitalized Patients with Severe COVID-19
From Business Wire News Releases
Alexion Highlights Commercial, Clinical and Financial Progress at the 39th Annual J.P. Morgan Healthcare Conference
From Business Wire News Releases
ALXN March 5th Options Begin Trading
Tags Stocks
From Market News Video
ALEXION INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Alexion Pharmaceuticals, Inc. - ALXN
From Business Wire News Releases
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.